Market Overview:
The global artificial insemination instrument market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing demand for assisted reproductive technologies (ART) and rising prevalence of infertility. In addition, technological advancements in artificial insemination instruments are also contributing to the growth of this market. On the basis of type, micromanipulator systems accounted for the largest share of the global artificial insemination instrument market in 2017. This segment is expected to continue its dominance during the forecast period owing to its wide applicability across various ART procedures such as intracytoplasmic sperm injection (ICSI), embryo biopsy, and embryo transfer.
Product Definition:
An artificial insemination instrument is a device used to insert semen into the female reproductive tract. It may be a syringe, an injector gun, or an applicator. The instrument helps to ensure that the semen is deposited in the correct location for optimal chances of fertilization.
Micromanipulator Systems:
micromanipulator systems are used in artificial insemination instrument market for sperm selection, monitoring of fertilization process and controlling the rate of fire. These devices are also used to measure the speed and force applied during penetration.
The global micromanipulator systems market was valued at USD 856.1 million in 2013.
Laser Systems:
Laser systems are used in artificial insemination instrument for semen extenders and cooling. It is a device that produces light, typically from a laser diode, which is then directed into the reproductive tract of the male. The light beam causes heat to be generated by friction, thus increasing the temperature of the sperm cells and making them swim faster towards the cervix where they can reach an egg cell.
Asia Pacific Laser Systems.
Application Insights:
Based on application, the market is segmented into fertility centers, hospitals and clinics, research institutes, and cryobanks. The fertility centers segment dominated the global artificial insemination instrument market in 2017 owing to factors such as rising adoption of these devices for assisted reproductive technology procedures at private practices. This trend is expected to continue over the forecast period due to increasing awareness about advanced infertility treatments among individuals desiring baby-making capabilities.
The Hospitals & Clinics segment accounted for a significant share of 22% in 2017 owing to an increase in number of IVF procedures being performed at hospitals and clinics across various regions including North America and Europe. In addition, presence of prominent players with experience working closely with medical teams from top-tier institutions further propels growth prospects within this region during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing infertility rates, rising adoption of frozen embryo transfer, and technological advancements in the field of artificial insemination. According to a study published by National Center for Health Statistics (NCHS), around 6 million women were infertile due toovulatory disorders or other causes from 2010 to 2014.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to factors such as improving healthcare infrastructure and fertility awareness programs being conducted across various countries such as India and China.
Growth Factors:
- Increasing demand for livestock products: The global population is increasing at a rapid pace and the demand for livestock products is also rising in tandem. This is driving the adoption of artificial insemination as it helps improve the quality and quantity of livestock produce.
- Rising awareness about benefits of AI: There is a growing awareness about the benefits of artificial insemination among farmers and other stakeholders. This is helping to drive its uptake across regions.
- Technological advancements: The technology underpinning artificial insemination continues to evolve, offering new opportunities for growth in this market space. For instance, developments such as embryo transfer are helping to improve productivity rates among animals undergoing AI procedures.
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Insemination Instrument Market Research Report
By Type
Micromanipulator Systems, Laser Systems, Imaging Systems, Ovum Aspiration Pumps, Sperm Analyzers, Incubators, Gas Analyzers, Others
By Application
Fertility Centers, Hospitals and Clinics, Research Institutes, Cryobanks
By Companies
The Cooper Companies Inc. (U.S.), Cook Group Incorporated (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Vitrolife AB (Sweden), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (U.S.), The Baker Company, Inc. (U.S.), The Cooper Companies Inc. (U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Artificial Insemination Instrument Market Report Segments:
The global Artificial Insemination Instrument market is segmented on the basis of:
Types
Micromanipulator Systems, Laser Systems, Imaging Systems, Ovum Aspiration Pumps, Sperm Analyzers, Incubators, Gas Analyzers, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fertility Centers, Hospitals and Clinics, Research Institutes, Cryobanks
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- The Cooper Companies Inc. (U.S.)
- Cook Group Incorporated (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Vitrolife AB (Sweden)
- Esco Micro Pte. Ltd. (Singapore)
- Genea Limited (Australia)
- IVFtech ApS (Denmark)
- Irvine Scientific (U.S.)
- The Baker Company, Inc. (U.S.)
- The Cooper Companies Inc. (U.S.)
Highlights of The Artificial Insemination Instrument Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Micromanipulator Systems
- Laser Systems
- Imaging Systems
- Ovum Aspiration Pumps
- Sperm Analyzers
- Incubators
- Gas Analyzers
- Others
- By Application:
- Fertility Centers
- Hospitals and Clinics
- Research Institutes
- Cryobanks
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Insemination Instrument Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Artificial Insemination Instrument is a medical device that is used to inseminate a woman's ovum.
Some of the major players in the artificial insemination instrument market are The Cooper Companies Inc. (U.S.), Cook Group Incorporated (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Vitrolife AB (Sweden), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (U.S.), The Baker Company, Inc. (U.S.), The Cooper Companies Inc. (U.S.).
The artificial insemination instrument market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Artificial Insemination Instrument Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Artificial Insemination Instrument Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Artificial Insemination Instrument Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Artificial Insemination Instrument Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Artificial Insemination Instrument Market Size & Forecast, 2020-2028
4.5.1 Artificial Insemination Instrument Market Size and Y-o-Y Growth
4.5.2 Artificial Insemination Instrument Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Micromanipulator Systems
5.2.2 Laser Systems
5.2.3 Imaging Systems
5.2.4 Ovum Aspiration Pumps
5.2.5 Sperm Analyzers
5.2.6 Incubators
5.2.7 Gas Analyzers
5.2.8 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Fertility Centers
6.2.2 Hospitals and Clinics
6.2.3 Research Institutes
6.2.4 Cryobanks
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Artificial Insemination Instrument Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Artificial Insemination Instrument Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Micromanipulator Systems
9.6.2 Laser Systems
9.6.3 Imaging Systems
9.6.4 Ovum Aspiration Pumps
9.6.5 Sperm Analyzers
9.6.6 Incubators
9.6.7 Gas Analyzers
9.6.8 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Fertility Centers
9.10.2 Hospitals and Clinics
9.10.3 Research Institutes
9.10.4 Cryobanks
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Micromanipulator Systems
10.6.2 Laser Systems
10.6.3 Imaging Systems
10.6.4 Ovum Aspiration Pumps
10.6.5 Sperm Analyzers
10.6.6 Incubators
10.6.7 Gas Analyzers
10.6.8 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Fertility Centers
10.10.2 Hospitals and Clinics
10.10.3 Research Institutes
10.10.4 Cryobanks
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Micromanipulator Systems
11.6.2 Laser Systems
11.6.3 Imaging Systems
11.6.4 Ovum Aspiration Pumps
11.6.5 Sperm Analyzers
11.6.6 Incubators
11.6.7 Gas Analyzers
11.6.8 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Fertility Centers
11.10.2 Hospitals and Clinics
11.10.3 Research Institutes
11.10.4 Cryobanks
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Micromanipulator Systems
12.6.2 Laser Systems
12.6.3 Imaging Systems
12.6.4 Ovum Aspiration Pumps
12.6.5 Sperm Analyzers
12.6.6 Incubators
12.6.7 Gas Analyzers
12.6.8 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Fertility Centers
12.10.2 Hospitals and Clinics
12.10.3 Research Institutes
12.10.4 Cryobanks
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Micromanipulator Systems
13.6.2 Laser Systems
13.6.3 Imaging Systems
13.6.4 Ovum Aspiration Pumps
13.6.5 Sperm Analyzers
13.6.6 Incubators
13.6.7 Gas Analyzers
13.6.8 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Fertility Centers
13.10.2 Hospitals and Clinics
13.10.3 Research Institutes
13.10.4 Cryobanks
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Artificial Insemination Instrument Market: Competitive Dashboard
14.2 Global Artificial Insemination Instrument Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 The Cooper Companies Inc. (U.S.)
14.3.2 Cook Group Incorporated (U.S.)
14.3.3 Thermo Fisher Scientific, Inc. (U.S.)
14.3.4 Vitrolife AB (Sweden)
14.3.5 Esco Micro Pte. Ltd. (Singapore)
14.3.6 Genea Limited (Australia)
14.3.7 IVFtech ApS (Denmark)
14.3.8 Irvine Scientific (U.S.)
14.3.9 The Baker Company, Inc. (U.S.)
14.3.10 The Cooper Companies Inc. (U.S.)
